Clinical Trial Update: Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of Phase 1/2 studies assessing spironolactone for chronic non-resolutive central serous chorioretinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinitis

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Central Serous Chorioretinitis | Phase 1, Phase 2 | Status: COMPLETED